RU95102269A - PRIMARY LIVER CANCER TREATMENT - Google Patents
PRIMARY LIVER CANCER TREATMENTInfo
- Publication number
- RU95102269A RU95102269A RU95102269/14A RU95102269A RU95102269A RU 95102269 A RU95102269 A RU 95102269A RU 95102269/14 A RU95102269/14 A RU 95102269/14A RU 95102269 A RU95102269 A RU 95102269A RU 95102269 A RU95102269 A RU 95102269A
- Authority
- RU
- Russia
- Prior art keywords
- liver cancer
- cancer treatment
- primary liver
- primary
- treatment
- Prior art date
Links
- 201000007270 liver cancer Diseases 0.000 title claims 2
- 102000013529 alpha-Fetoproteins Human genes 0.000 claims 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU95102269A RU2058153C1 (en) | 1995-02-20 | 1995-02-20 | Preparation for primary liver cancer treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU95102269A RU2058153C1 (en) | 1995-02-20 | 1995-02-20 | Preparation for primary liver cancer treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2058153C1 RU2058153C1 (en) | 1996-04-20 |
RU95102269A true RU95102269A (en) | 1998-10-27 |
Family
ID=20164883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95102269A RU2058153C1 (en) | 1995-02-20 | 1995-02-20 | Preparation for primary liver cancer treatment |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2058153C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2179452C1 (en) | 2000-06-22 | 2002-02-20 | Пак Владимир Николаевич | Method to treat malignant neoplasms and combined preparation of antitumor action to perform the method |
-
1995
- 1995-02-20 RU RU95102269A patent/RU2058153C1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2013020I2 (en) | THE USE OF AN INGENANE COMPOUND FOR THE MANUFACTURE OF A MEDICINE FOR THE TREATMENT OF CANCER | |
IS2011B (en) | A compound for the treatment of cancer | |
FR2712666B1 (en) | Luminaire for medical application. | |
DE627896T1 (en) | SURGICAL ENDOCLIP. | |
TR199800436A3 (en) | The use of primidine derivatives for cancer prevention. | |
MX9102473A (en) | PHARMACEUTICAL AGENTS. | |
NO941142D0 (en) | Tumor nekrosefaktormuteiner | |
DK0769017T3 (en) | Therapeutic compounds | |
FI971568A (en) | Procedure for the treatment of resistant tumors | |
BR9609093A (en) | Use of bis-1,2,4-triazoles for the production of a cancer treatment drug | |
BR9610214A (en) | Pharmaceutical compounds | |
NO975662D0 (en) | Use of 1,2,4-triazole derivatives for the preparation of a drug for the treatment of cancer | |
FI931142A0 (en) | ANORDNING FOER VAERMEBEHANDLING AV OPHTHALM LINKER, SPECIELLT CONTACT LINER | |
FI943880A (en) | Modified tumor cytotoxic factor | |
NO954702D0 (en) | Aryl forming drugs | |
FI923486A (en) | THERAPEUTIC AEMNEN. | |
MX9207407A (en) | IMPROVING THE BIOAVAILABILITY OF PROTEOLITICALLY LABIL THERAPEUTIC AGENTS. | |
RU95102269A (en) | PRIMARY LIVER CANCER TREATMENT | |
TR199601018A1 (en) | Pharmaceutical compounds. | |
LV11966A (en) | Anti-inflammatory medication for use | |
FR2680293B1 (en) | FAR ECHO CANCER. | |
FI910753A (en) | THERAPEUTIC NUCLEOCIDER. | |
RU95112970A (en) | MEANS FOR CORRECTION OF HYPERLIPIDEMIA | |
IT1295973B1 (en) | PROCEDURE FOR LIGHTING OBJECTS. | |
FI923528A (en) | THERAPEUTIC AEMNEN. |